The AiMS Study: Assessing the impact of Monoclonal gammopathy of undetermined significance (MGUS). A pilot study (2016)
Attributed to:
The Centre of Excellence for Public Health (NI) - Phase II (CoEfPHNI/II)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 25
Parent Publication: PSYCHO-ONCOLOGY
Issue: SP. S3
ISSN: 1057-9249